<!doctype html>
<html>
  <head>
    <meta charset="utf-8">
    <link rel="shortcut icon" href="http://columbiasurgery.org/sites/default/files/csun-logo-favicon.png" type="image/png">
    <meta name="description" content="Aldosterone helps control blood pressure by holding onto salt and losing potassium from">
    <meta name="generator" content="Drupal 7 (http://drupal.org)">
    <link rel="canonical" href="http://columbiasurgery.org/conditions-and-treatments/primary-hyperaldosteronism-conns-syndrome">
    <link rel="shortlink" href="http://columbiasurgery.org/node/974">
    <title>Primary Hyperaldosteronism (Conn's Syndrome) | Columbia University Department of Surgery</title>
    <meta name="MobileOptimized" content="width">
    <meta name="HandheldFriendly" content="true">
    <meta name="viewport" content="width=device-width">
    <meta http-equiv="cleartype" content="on">
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_lQaZfjVpwP_oGNqdtWCSpJT1EMqXdMiU84ekLLxQnc4.css" media="all">
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_VcDspnWP3DWMrx8fnDk_VSO1QQ64dsY5vPEnv5-wYus.css" media="all">
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_gxditrUJQNmvNGakpxeXIcUmZMna8o6VpHvI-nC8SFQ.css" media="all">
    <style>#views-exposed-form-clinical-trials-panel-pane-1 .views-exposed-form{display:none}
    </style>
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_FNHRCFV_j_V0s1c9VdkenzL7obIg9i0SrQ_k2k2gkkg.css" media="all">
    <style>
.panels-flexible-new .panels-flexible-region{padding:0}.panels-flexible-new .panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-region-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-region-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-column{padding:0}.panels-flexible-new .panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-column-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-column-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-row{padding:0 0 .5em;margin:0}.panels-flexible-new .panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99%}.panels-flexible-row-new-main-row-inside{padding-right:0}
    </style>
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_DpfS8HLVrIo6PPlHTTJhv8Vj1ZlTpLp9GA_7aYcXWAk.css" media="all">
    <style>
.panels-flexible-new .panels-flexible-region{padding:0}.panels-flexible-new .panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-region-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-region-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-column{padding:0}.panels-flexible-new .panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-column-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-column-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-row{padding:0 0 .5em;margin:0}.panels-flexible-new .panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99%}.panels-flexible-row-new-main-row-inside{padding-right:0}
    </style>
    <link type="text/css" rel="stylesheet" href="http://columbiasurgery.org/sites/default/files/css/css_pZlYDZQcT-6YBrU-ayJC-R5HcXOgpQqdWCEX-YqVOAM.css" media="all">
    <script type="text/javascript" async="" src="https://www.google-analytics.com/gtm/js?id=GTM-WK3WTHV&amp;cid=359471621.1537698862"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script type="text/javascript" src="//www.googletagmanager.com/gtm.js?id=GTM-572XFD7" async=""></script><script src="http://columbiasurgery.org/sites/default/files/js/js_qvvDbAjKzXCqJ3xD6pofZI10u--7VyN8ZJr0EbcNB4Y.js"></script>
    <script src="http://columbiasurgery.org/sites/default/files/js/js_x0MhBQfHNAIO1NwkQgzf_TGN4b8eMmKre3nqUfoQv3w.js"></script>
    <script src="http://columbiasurgery.org/sites/default/files/js/js_DzD04PZATtGOFjfR8HJgfcaO3-pPZpWFXEvuMvQz2gA.js"></script>
    <script src="http://columbiasurgery.org/sites/default/files/js/js_FmmFL0X00ME9qpcpWIwaLwtd3ldjLpM3abf1BLFgWfA.js"></script>
    <script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-2083570-5", {"cookieDomain":"auto"});ga('require', 'GTM-WK3WTHV');ga("send", "pageview");</script>
    <script src="http://columbiasurgery.org/sites/default/files/js/js_r9p12DhdkpD6Skcv5P884Yym85k42EITbZQyqMIN81c.js"></script>
    <script src="//use.typekit.net/rxg5fjz.js"></script>
    <style type="text/css">.tk-minion-pro{font-family:"minion-pro",sans-serif;}</style><style type="text/css">@font-face{font-family:minion-pro;src:url(https://use.typekit.net/af/205092/0000000000000000000151d1/23/l?subset_id=2&fvd=n7&v=3) format("woff2"),url(https://use.typekit.net/af/205092/0000000000000000000151d1/23/d?subset_id=2&fvd=n7&v=3) format("woff"),url(https://use.typekit.net/af/205092/0000000000000000000151d1/23/a?subset_id=2&fvd=n7&v=3) format("opentype");font-weight:700;font-style:normal;}@font-face{font-family:minion-pro;src:url(https://use.typekit.net/af/c90ebf/0000000000000000000151d2/23/l?subset_id=2&fvd=i7&v=3) format("woff2"),url(https://use.typekit.net/af/c90ebf/0000000000000000000151d2/23/d?subset_id=2&fvd=i7&v=3) format("woff"),url(https://use.typekit.net/af/c90ebf/0000000000000000000151d2/23/a?subset_id=2&fvd=i7&v=3) format("opentype");font-weight:700;font-style:italic;}@font-face{font-family:minion-pro;src:url(https://use.typekit.net/af/94bd2d/0000000000000000000151d3/23/l?subset_id=2&fvd=i4&v=3) format("woff2"),url(https://use.typekit.net/af/94bd2d/0000000000000000000151d3/23/d?subset_id=2&fvd=i4&v=3) format("woff"),url(https://use.typekit.net/af/94bd2d/0000000000000000000151d3/23/a?subset_id=2&fvd=i4&v=3) format("opentype");font-weight:400;font-style:italic;}@font-face{font-family:minion-pro;src:url(https://use.typekit.net/af/deb88c/0000000000000000000151d6/23/l?subset_id=2&fvd=n4&v=3) format("woff2"),url(https://use.typekit.net/af/deb88c/0000000000000000000151d6/23/d?subset_id=2&fvd=n4&v=3) format("woff"),url(https://use.typekit.net/af/deb88c/0000000000000000000151d6/23/a?subset_id=2&fvd=n4&v=3) format("opentype");font-weight:400;font-style:normal;}</style><script>try{Typekit.load();}catch(e){}</script>
    <script src="//fast.fonts.net/jsapi/fd3cd210-e71c-4cec-a23c-c60f02178ded.js"></script>
    <script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"base","theme_token":"5Hxt61TfPQdsJo5JFpiI1D_GTCStehCQHa1NoFtGKVs","js":{"sites\/all\/themes\/base\/js\/script.js":1,"sites\/all\/themes\/base\/fonts\/ss-icons.js":1,"public:\/\/google_tag\/google_tag.script.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.accordion.min.js":1,"sites\/all\/themes\/base\/js\/accordion.js":1,"sites\/all\/modules\/patched\/megamenu\/megamenu.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"0":1,"sites\/all\/modules\/contrib\/google_analytics_et\/js\/google_analytics_et.js":1,"\/\/use.typekit.net\/rxg5fjz.js":1,"1":1,"\/\/fast.fonts.net\/jsapi\/fd3cd210-e71c-4cec-a23c-c60f02178ded.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/custom\/custom\/custom.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/mollom\/mollom.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/alpha_pagination\/css\/alpha_pagination.css":1,"0":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/all\/modules\/contrib\/wysiwyg_linebreaks\/wysiwyg_linebreaks.css":1,"1":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"2":1,"sites\/all\/themes\/base\/system.menus.css":1,"sites\/all\/themes\/base\/system.messages.css":1,"sites\/all\/themes\/base\/system.theme.css":1,"sites\/all\/themes\/base\/css\/styles.css":1}},"megamenu":{"timeout":"500","sizewait":"250","hoverwait":"400"},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"googleAnalyticsETSettings":{"selectors":[{"event":"mousedown","selector":".megamenu-parent h2","category":"interaction","action":"mega menu","label":"!text","value":1,"noninteraction":false,"options":{"trackOnce":false}},{"event":"mousedown","selector":".megamenu-bin a","category":"navigation","action":"mega menu","label":"!text","value":1,"noninteraction":false,"options":{"trackOnce":false}},{"event":"mousedown","selector":".level-3 a","category":"navigation","action":"specialties footer menu","label":"!text","value":1,"noninteraction":false,"options":{"trackOnce":false}},{"event":"mousedown","selector":".footer__list--item a","category":"navigation","action":"footer menu","label":"!text","value":1,"noninteraction":false,"options":{"trackOnce":false}},{"event":"mousedown","selector":".level-1 a","category":"navigation","action":"sidebar menu","label":"!text","value":1,"noninteraction":false,"options":{"trackOnce":false}}],"settings":[]},"urlIsAjaxTrusted":{"\/conditions-and-treatments\/primary-hyperaldosteronism-conns-syndrome":true},"ogContext":{"groupType":"node","gid":"964"}});</script>
    <!--[if lt IE 9]>
      <script src="/sites/all/themes/zen/js/html5-respond.js"></script>
    <![endif]--><style type="text/css" id="mti_fontface_fd3cd210-e71c-4cec-a23c-c60f02178ded">
@font-face{font-family:"Avenir LT W01 35 Light";src:url(http://fast.fonts.net/dv2/3/c4352a95-7a41-48c1-83ce-d8ffd2a3b118.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-35LightObli";src:url(http://fast.fonts.net/dv2/3/47fd1045-6e5b-4c87-9235-cfbc2b42cde7.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"Avenir LT W01 45 Book";src:url(http://fast.fonts.net/dv2/3/939cba03-5b40-4d01-9bc5-7589eca863db.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-45BookObliq";src:url(http://fast.fonts.net/dv2/3/ca94ed56-18fc-4856-940a-70a072607c7c.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"Avenir LT W01 55 Roman";src:url(http://fast.fonts.net/dv2/3/b9ebb19d-88c1-4cbd-9baf-cf51972422ec.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-55Oblique";src:url(http://fast.fonts.net/dv2/3/3695342c-b5e2-4010-b0d4-56f563465922.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"Avenir LT W01 65 Medium";src:url(http://fast.fonts.net/dv2/3/2cac77ec-9bc0-4ee7-87e4-27650190744f.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-65MediumObl";src:url(http://fast.fonts.net/dv2/3/e0af2f49-a399-482b-a54e-d745e268ec80.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"Avenir LT W01 85 Heavy";src:url(http://fast.fonts.net/dv2/3/7147ec3a-8ff8-4ec9-8c5c-bd1571dc6ae6.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-85HeavyObli";src:url(http://fast.fonts.net/dv2/3/53554f6f-4b01-4815-87fe-82c49b8ba5a9.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"Avenir LT W01 95 Black";src:url(http://fast.fonts.net/dv2/3/5a05cf7f-f332-456f-ae67-d8c26e0d35b3.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}@font-face{font-family:"AvenirLTW01-95BlackObli";src:url(http://fast.fonts.net/dv2/3/36ec15b9-f8da-447f-8fed-a9cfdfb91fbb.woff?d44f19a684109620e484167bae90e8180d1961f85d1ae2fffdac0218cc807ef6443758aeb639077aa436604fe397b801ed5bfb758728f184fbdb5108353e621e206add9ec6aeaf91c42e91604f2eed7911b263824f0a0420fb25032fde2fd1ab9104804b1791cdb06881117bfd1fbd37028f6543ea795010caab2dc05cde7a00778f06cf0ce90748cd7518070228cdba2359505bef5394eb936f52eb022fe6a5c78476091826ad04bef2375dd260b227fb41a18169b07acfdae0f58d806e068a50812ef51ed439805d2ea87e101ee3f1ef7b8c20aa4969b19792371249b9c9fed4936f1d47&projectId=fd3cd210-e71c-4cec-a23c-c60f02178ded) format('woff')}
    </style>
    <link id="MonoTypeFontApiFontTracker" type="text/css" rel="stylesheet" href="http://fast.fonts.net/t/1.css?apiType=js&amp;projectid=fd3cd210-e71c-4cec-a23c-c60f02178ded">
  </head>
  <body>
    <div id="content" class="column" role="main">
      <a id="main-content"></a>
      <section class="main-top">
        <div class="panel-pane pane-block pane-block-6 social-links">
          <h2 class="pane-title pane__title social-links__title">Social Links</h2>
          <ul class="social"><li class="social__link"><a class="social__icon" href="https://www.facebook.com/columbiasurgery" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/facebook.png" alt=""></a></li>
            <li class="social__link"><a class="social__icon" href="https://plus.google.com/117851048752288283671/" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/googleplus.png" alt=""></a></li>
            <li class="social__link"><a class="social__icon" href="https://twitter.com/columbiasurgery" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/twitter.png" alt=""></a></li>
            <li class="social__link"><a class="social__icon" href="http://www.youtube.com/user/ColumbiaSurgery" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/youtube.png" alt=""></a></li>
            <li class="social__link"><a class="social__icon" href="http://www.sharecare.com/group/columbia-university-department-of-surgery" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/sharecare.png" alt=""></a></li>
            <li class="social__link"><a class="social__icon" href="http://www.blogtalkradio.com/columbiasurgery" target="_blank"><img src="http://columbiasurgery.org/sites/all/themes/base/images/blogtalk.png" alt=""></a></li>
          </ul>
        </div>
        <div class="panel-pane pane-token pane-node-title">
          <h1 class="general-page__title">Primary Hyperaldosteronism (Conn's Syndrome)</h1>
        </div>
      </section>
      <div class="content-main">
        <div class="panel-pane pane-token pane-node-body">
          <p><div class="image-wrapper-with-caption right" style="width:250px;"><img src="http://columbiasurgery.org/sites/default/files/styles/large/public/adrenal_adenoma_ct.jpg?itok=ajrVRPxU" alt="Adrenal adenoma on CT" title="Adrenal adenoma on CT" class="right" info="%22media%22%7D" width="250" height="213"><div class="image-caption">Adrenal adenoma on CT</div></div>Aldosterone helps control blood pressure by holding onto salt and losing potassium from the blood. The increased salt increases the blood pressure. <strong><em>Hyperaldosteronism</em></strong> is a disease in which the adrenal gland(s) make too much aldosterone which leads to <strong>hypertension</strong> (<strong>high blood pressure</strong>) and low blood potassium levels.</p>
          <p><strong>Primary hyperaldosteronism</strong> can be caused by either hyperactivity in one <strong>adrenal gland</strong> (unilateral disease) or both (bilateral disease). Unilateral disease is usually caused by an aldosterone producing adenoma (benign tumor) and less commonly by adrenal cancer or hyperplasia (when the whole gland is hyperactive). Bilateral disease is usually caused by bilateral hyperplasia (when both glands are hyperactive). There are rare genetic syndromes like familial hyperaldosteronism type I and II which may cause both glands to be hyperactive.</p>
        </div>
        <div class="panel-pane pane-entity-field pane-node-field-sections">
          <div class="field-collection-container clearfix"><section id="accordion" class="section effect--accordion ui-accordion ui-widget ui-helper-reset" role="tablist">
              <div class="field-collection-view clearfix view-mode-full">
                <h2 class="ui-accordion-header ui-helper-reset ui-state-default ui-corner-all" role="tab" id="ui-accordion-accordion-header-0" aria-controls="ui-accordion-accordion-panel-0" aria-selected="false" tabindex="-1">
                  Signs and Symptoms  </h2>
                <div class="ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom" style="display: none;" id="ui-accordion-accordion-panel-0" aria-labelledby="ui-accordion-accordion-header-0" role="tabpanel" aria-expanded="false" aria-hidden="true">
                  <p>High blood pressure is often the only sign of <strong>hyperaldosteronism</strong>. The hypertension is usually hard to control and patients are often on 4 or more blood pressure medications. The hypertension may cause headaches, blurred vision, and dizziness. While patients with hyperaldosteronism may have normal potassium levels, many patients may have low potassium levels. The hypokalemia (low potassium level) can cause symptoms like fatigue, numbness, increased urination, increased thirst, muscle cramps, and muscle weakness. Hyperaldosteronism leads to an increased risk for heart attacks, heart failure, strokes, kidney failure, and early death.</p>
                </div>
              </div>        <div class="field-collection-view clearfix view-mode-full">
                <h2 class="ui-accordion-header ui-helper-reset ui-state-default ui-corner-all" role="tab" id="ui-accordion-accordion-header-1" aria-controls="ui-accordion-accordion-panel-1" aria-selected="false" tabindex="-1">
                  Diagnosis  </h2>
                <div class="ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom" style="display: none;" id="ui-accordion-accordion-panel-1" aria-labelledby="ui-accordion-accordion-header-1" role="tabpanel" aria-expanded="false" aria-hidden="true">
                  <p><strong>Primary hyperaldosteronism</strong> is diagnosed by measuring the blood levels of aldosterone and renin (a hormone made by the kidney). To best measure these hormones, blood samples should be drawn in the morning. In primary hyperaldosteronism, the aldosterone level will be high while renin will be low or undetectable. The potassium level may be low or normal. If these tests are positive, then patients may have another test to confirm the diagnosis. These tests try to lower the amount of aldosterone produced either by giving a medication or giving extra salt through the diet or an intravenous fluid. If the aldosterone level is high and the renin level is low after these tests, the diagnosis is confirmed. Some medications, especially blood pressure medications, can interfere with these tests. Your physician will review your medications and decide if any need to be stopped for 4 to 6 weeks prior to testing. In general, patients with a long-standing history of hypertension or difficult to control hypertension should be screened for hyperaldosteronism.</p>
                  <ul><li>
                      <h4>PAC:PRA ratio</h4>
                      <p>This <strong>blood test</strong> is a screening test, meaning that it is performed if hyperaldosteronism is suspected but not yet diagnosed. A high ratio of PAC to PRA suggests primary hyperaldosteronism, but additional testing may be needed to confirm the diagnosis.</p>
                    </li>
                    <li>
                      <h4>Captopril Suppression Test</h4>
                      <p>This <strong>blood test</strong> measures the body's response to captopril, a medication used to treat high blood pressure. Results of this test can confirm whether a person has primary hyperaldosteronism.</p>
                    </li>
                    <li>
                      <h4>24-hour Urinary Excretion of Aldosterone Test</h4>
                      <p>Patients eat a high-salt diet for five days, and then undergo <strong>urine tests</strong> during a 24-hour period. If the level of aldosterone in the urine is high, such results can confirm that a patient has primary hyperaldosteronism.</p>
                    </li>
                    <li>
                      <h4>Saline Suppression Test</h4>
                      <p>In this test, the patient receives a salt <strong>solution through an IV</strong>. A blood test then measures the patient's levels of aldosterone and renin. Primary hyperaldosteronism can be confirmed if the level of aldosterone in the blood remains high and renin is low after this salt loading.</p>
                    </li>
                  </ul>  </div>
              </div>        <div class="field-collection-view clearfix view-mode-full">
                <h2 class="ui-accordion-header ui-helper-reset ui-state-default ui-corner-all" role="tab" id="ui-accordion-accordion-header-2" aria-controls="ui-accordion-accordion-panel-2" aria-selected="true" tabindex="0">
                  Localization  </h2>
                <div class="ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom ui-accordion-content-active" style="display: block;" id="ui-accordion-accordion-panel-2" aria-labelledby="ui-accordion-accordion-header-2" role="tabpanel" aria-expanded="true" aria-hidden="false">
                  <p><a href="/stories/jm-s-story"><div class="image-wrapper-with-caption left" style="width:250px;"><img src="http://columbiasurgery.org/sites/default/files/styles/large/public/doctor_morrissey_catheter.jpg?itok=liRtrC_i" alt="Dr. Morrissey demonstrates the catheter used in Adrenal Venous Sampling. Click here to see the full article." title="Dr. Morrissey demonstrates the catheter used in Adrenal Venous Sampling" class="left" info="%22media%22%7D" width="250" height="397"><div class="image-caption">Dr. Morrissey demonstrates the catheter used in Adrenal Venous Sampling. Click here to see the full article.</div></div></a>For patients with proven primary hyperaldosteronism, the next step is to figure out if this is unilateral or bilateral disease. This is critical because the treatment for each is different. A computed tomography (CT or CAT) scan or magnetic resonance imaging (MRI) scan will be done to see if there is a tumor in either adrenal gland. If the patient is younger than 40 years old and there is a tumor in only one adrenal (especially if it is between 1 and 2 cm), then the patient may go directly to treatment. If the patient is older than 40 and/or there is either no tumor seen or tumors in both adrenals, then the patient will have a special test called selective venous sampling. In this test, a surgeon or radiologist will draw blood directly from the veins draining both adrenal glands to determine if one or both are making too much hormone. Significantly higher hormone levels on one side only clinches the diagnosis of unilateral disease. Selective venous sampling is usually done as an outpatient procedure.</p>
                </div>
              </div>        <div class="field-collection-view clearfix view-mode-full field-collection-view-final">
                <h2 class="ui-accordion-header ui-helper-reset ui-state-default ui-corner-all ui-state-focus" role="tab" id="ui-accordion-accordion-header-3" aria-controls="ui-accordion-accordion-panel-3" aria-selected="false" tabindex="-1">
                  Treatment  </h2>
                <div class="ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom" style="display: none;" id="ui-accordion-accordion-panel-3" aria-labelledby="ui-accordion-accordion-header-3" role="tabpanel" aria-expanded="false" aria-hidden="true">
                  <p>The <strong>treatment for hyperaldosteronism</strong> depends on the underlying cause. In patients with a single benign tumor (<em>adenoma</em>), surgical removal (<em>adrenalectomy</em>) is curative. This operation is usually performed laparoscopically, through several very small incisions. (See <a href="/conditions-and-treatments/adrenal-surgery">Adrenal Surgery</a>) After successful adrenalectomy, approximately 95% of patients notice significant improvement in their hypertension. Of this 95%, one third are cured of high blood pressure and the rest are on fewer medications or lower dosages. For patients with bilateral hyperplasia, the best treatment is a medication called an aldosterone-antagonist (spironolactone, eplerenone) which blocks the effect of aldosterone. In addition, patients are maintained on a low salt diet.</p>
                  <p>Without proper treatment, patients with hyperaldosteronism often suffer from poorly controlled high blood pressure and are at increased risk for heart attacks, heart failure, strokes, kidney failure, and early death. However, with appropriate treatment, this disease is treatable and has an excellent prognosis. Patients with difficult to control or long-standing hypertension should be screened for primary hyperaldosteronism.</p>
                </div>
              </div>    </section></div>
        </div>
      </div>
    </div>
  </body>
</html>
